Basophilic Blast crisis of CML- Barely encountered
Abstract
Objective: Chronic leukemias are rare and blastic phase of CML are even rare. Imunophenotyping/IHC studies have a limited role in the diagnosis of CML but are being used in CMl blast transformations. Purpose of this current study was to report the barely encountered basophilic blast crisis of CML .and to determine the clinical and laboratory and Flow immunophenotyping (FIC)/IHC features of blast crisis. Methods: 8 years analysis was done 688 cases of suspected CMI were studied . Patients were evaluated at KMIO between 2004 to 2012. 488 cases had Bone marrow diagnosis of CML. 42 cases peripheral smear was suggestive of blastic phase CML were selectively chosen for the study. Bone marrow , Karyotyping and Molecular confirmation was available . IHC /FIC was done in 15 cases. Results: adults and Male sex predilection was seen. Gender ratio was 1.6: 1.splenomegaly& Leucocyte count> 200X10° I was seen, in all cases bone marrorw aspiration confirmed the diagnosis,most cases of CML progressed to blastic phase from chronic phase during their course of treatment. Phildelphia chromosome was noted in most cases.and 6 cases revealed additional markers .PCR revealed p210 transcript in all cases. In 15 cases in the blastic phase Flow cytometry immunophenotype/IHC was done. 9 cases were myeloid blastic phase,2 cases were reported as basophilic blast crisis single case was mixed phenotype, 3 cases were lymphoid blastic phase. Conclusion: most treated cases attained remission with imatinib, continue to be in remission after a mean of 8 months.
Downloads
References
2. David P Steensma and Robert E Richard; American society of haematology ,3rd edition,Myeloproliferative disorders;:202-213, 2007.
3.Kunihiko Yamauchi and Shigeru Arimori:Basophilic crisis in Chronic Myelogenous Leukemia:case Report and literature review in Japan.Jpn J Med vol 29,no3 ,1990.
4.Denberg JA,Wilson WEC,Bienen stockJ:Basophil production in myeloproliferative disorders;increases during acute blastic transformation of chronic myeloid leukemia .Blood 60:113,1982.
5.lazzarino M M orra E ,Castello A et al Myelofibrosis in chronic granulocytic leukemia clinicopathologic correlations and prognostic significance.Br J Haematol 64 ; 227-240
6.Slovak ML, Gundacker H, Bloomfield CD et al.Aretrospective study of 69 patients with t(6:9)(p23:q34)AML emphasizes the need for a prospective multicenter initiation for rare poor prognosis myeloid malignancies.Leukemia20:1295-1297,2006.
7.Pearson MG ,Vardiman JW,LeBeau M M,et al. Increased numbers of marrow basophils may be associated with act(6;9) in ANLL.Am J Hematol 18:393,1985.
8. Stefan Faderl, ZeevEstrovRazelleKurzrock hagop M K antarjian. The biology of Chronic Myeloid Leukemia. The New England Journal of Medicine. 1999:15:165-172.
9. Goldman JM, Melo TV. Chronic myeloid leukemia--advances in biology and new approaches to treatment.N Engi] Med. 2003 Oct 9:349(15):1451-64.
10. Andolina JR. Neudorf SM. Corey SJ. How I teat childhood CML. Blood. 2012 Feb 23:119(S):1821-30 đoi: 10.1182/blood-2011-10-380774. Epub 2011 Dec
Copyright (c) 2024 Author (s). Published by Siddharth Health Research and Social Welfare Society
This work is licensed under a Creative Commons Attribution 4.0 International License.